1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. INTELLIA THERAPEUTICS INC
Intellia Therapeutics Inc XNAS: NTLA

Intellia Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Momentum Trap
about

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a rev...

Read More
9.56 -0.01 (-0.10%)
66.08% Fall from 52W High
3.2M
XNAS Volume

XNAS 25 Jun, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
15.3 / 100
Momentum Score
Technically Neutral
47.9 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
37
1Yr Price target upside is 290%
27 analysts

10

S

14

W

0

O

2

T

SWOT Analysis

Intellia Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Intellia Therapeutics Inc FAQ

How is Intellia Therapeutics Inc today?
Intellia Therapeutics Inc today is trading in the red, and is down by -0.10% at 9.56.
Intellia Therapeutics Inc is currently trading down -0.10% on an intraday basis. In the past week the stock fell -0.21%. stock has been up 2.69% in the past quarter and fell -61.76% in the past year. You can view this in the overview section.